ESRD Facility Medicare Audit: OIG Findings on Improper Payments and How to Prevent Them

A guide to Medicare audits of dialysis facilities: how the ESRD PPS works in 2026 and 2027, OIG provider compliance audit findings on assessments, plans of care, treatments, height and weight, and physician notes, the ongoing home dialysis audit, consolidated billing, and prevention strategies.

KNOWLEDGE CENTER

11/15/202612 min read

Medicare is the dominant payer for dialysis. Under the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), CMS pays certified ESRD facilities a bundled per-treatment payment that covers dialysis and most related drugs, laboratory tests, equipment, and supplies. CMS expected to pay about $6.9 billion to approximately 7,600 ESRD facilities in calendar year 2026, according to the proposed rule.

That scale, together with the complexity of bundled payment and the ESRD conditions for coverage, makes dialysis facilities a recurring audit target. OIG has conducted a series of provider compliance audits of dialysis facilities, finding claims that did not meet Medicare requirements because of incomplete assessments and plans of care, treatments that were not completed or documented, measurement errors, and missing physician progress notes. OIG is also conducting an audit of home dialysis services, with results expected in fiscal year 2026.

This article explains the ESRD PPS, OIG's findings, other audit risks, and how facilities can prevent improper payments. It is educational and does not replace legal or professional advice.

How the ESRD PPS Works

Base Rate and Adjustments

For calendar year 2026, CMS set the ESRD PPS base rate at $281.71 per treatment. On October 28, 2026, CMS issued the CY 2027 final rule, setting the base rate at $297.52 beginning January 1, 2027, an increase that includes $12.85 to reflect the inclusion of phosphate binders in the base rate.

The base rate is adjusted for patient-level factors, such as age, body surface area, body mass index, onset of dialysis, and certain comorbidities, and for facility-level factors, such as the wage index, low-volume status, and rural location. Pediatric patients have separate adjustments.

Outlier Payments

Facilities may receive outlier payments when the imputed cost of certain outlier services, such as ESRD-related drugs and laboratory tests, exceeds thresholds. Outlier payments depend on accurate reporting of drugs and services on claims.

TDAPA and Post-TDAPA Add-Ons

The transitional drug add-on payment adjustment (TDAPA) pays for certain new renal dialysis drugs and biological products for a limited period under 42 CFR 413.234. CMS also pays post-TDAPA add-on amounts for certain drugs. Phosphate binders, oral-only drugs that became part of the ESRD PPS in 2025 with TDAPA, are being incorporated into the base rate in 2027.

Consolidated Billing

Under the ESRD PPS, renal dialysis services, including ESRD-related laboratory tests, drugs, and supplies, are included in the bundled payment and must be billed by the ESRD facility. Other providers, such as laboratories and pharmacies, generally cannot bill Medicare separately for these services. Items and services unrelated to ESRD may be billed separately by other providers with the AY modifier, when supported by documentation that they are not related to the treatment of ESRD.

Treatment Frequency

Medicare generally pays for three hemodialysis treatments per week. Additional treatments are payable only when medically justified and documented. Home dialysis and peritoneal dialysis are paid on a per-treatment equivalent basis.

The Conditions for Coverage

ESRD facilities must meet the conditions for coverage in 42 CFR Part 494. Key requirements relevant to audits include:

Patient Assessment

Under 42 CFR 494.80, the interdisciplinary team must complete a comprehensive assessment of each patient, including evaluation of health status, dialysis prescription, laboratory profile, nutritional status, psychosocial needs, rehabilitation status, vascular access, and home dialysis suitability. Initial assessments for new patients must be completed within specified time frames, such as within 30 calendar days or 13 hemodialysis sessions, with follow-up reassessment within three months and at least annually for stable patients, and at least monthly for unstable patients.

Plan of Care

Under 42 CFR 494.90, the interdisciplinary team must develop and implement a written, individualized plan of care that addresses dose of dialysis, nutritional status, mineral metabolism, anemia, vascular access, psychosocial status, modality, rehabilitation, and transplantation status. The plan must be implemented within required time frames and updated to reflect reassessments.

Medical Records

Under 42 CFR 494.170, facilities must maintain complete, accurate, and accessible medical records for each patient.

Physician Oversight

Physicians or other qualified practitioners must see and evaluate patients periodically and document progress, and the medical director is responsible for quality assessment and performance improvement.

OIG's Provider Compliance Audits

The Dialysis Clinic, Inc. Audit

OIG's September 2022 audit of Dialysis Clinic, Inc. (A-05-20-00010) reviewed a random sample of 100 claims from 112,192 claims for calendar year 2018, for which DCI received about $276.4 million. OIG found that 70 of the 100 sampled claims did not comply with Medicare requirements, identifying five types of errors:

• Comprehensive assessments or plans of care that did not meet Medicare requirements.

• Dialysis treatments that were not completed.

• Dialysis services that were not documented.

• Height or weight measurements that did not comply with Medicare requirements.

• Medical records lacking a monthly progress note from a physician or other qualified professional.

OIG estimated that DCI received unallowable payments of at least $14.2 million and recommended refunds within the reopening period, use of the 60-day rule to identify and return additional overpayments, and improvements to medical record systems, weight measurement timing for home dialysis patients, and staff and beneficiary training. OIG noted that many errors did not affect reimbursement directly because services were paid on a bundled basis or related to coverage conditions, but could affect quality of care. DCI disagreed with the findings and sampling methodology, and OIG revised determinations for 15 claims but maintained its findings.

Other Facility Audits

OIG has conducted similar provider compliance audits of other dialysis organizations, including a 2020 audit of a Bio-Medical Applications facility in Puerto Rico. Earlier OIG reviews identified dialysis services that were medically unnecessary, not properly ordered, undocumented, or not compliant with consolidated billing requirements.

The Home Dialysis Audit

OIG announced in December 2023 an audit of Medicare Part B home dialysis services, which is reviewing whether home dialysis services complied with Medicare requirements and could affect quality of care. OIG's work plan describes the audit as following earlier findings of improper payments, including claims without treatment notes or documentation of dispensed medication, and estimates completion in fiscal year 2026.

Why These Errors Matter

Assessments and Plans of Care

Assessments and plans of care are conditions for coverage. When they are missing, late, or incomplete, OIG may treat the related claims as not meeting Medicare requirements.

Treatment Documentation

Each billed treatment must be furnished and documented. Treatments that are started but not completed, missed treatments, or treatments without flow sheets can be found improper.

Height and Weight

Body surface area and body mass index adjustments depend on height and weight measurements. CMS requires measurements to be taken and reported according to specific rules, and errors can affect payment.

Physician Progress Notes

Monthly physician or qualified practitioner documentation supports ongoing medical oversight. Missing notes can be cited even when the physician billed a monthly capitation payment.

Drugs and Labs

Accurate reporting of drugs and labs supports outlier payments, TDAPA, and anemia management monitoring. Missing administration records or dispensing documentation, especially for home patients, can lead to findings.

Other Audit Risks

Comorbidity Adjustments

Comorbidity payment adjustments require documentation of qualifying diagnoses within specified time frames. Unsupported comorbidity codes can lead to overpayments.

Onset of Dialysis Adjustment

The onset adjustment applies for the first months of dialysis and must be supported by accurate dates.

Low-Volume Adjustment

Facilities claiming the low-volume payment adjustment must meet treatment thresholds and attest accurately. MACs review eligibility.

Home Dialysis Training

Home dialysis training add-on payments require documentation of training sessions.

Acute Kidney Injury Dialysis

Dialysis for patients with acute kidney injury is paid at a separate rate and has specific billing requirements.

Medicare Secondary Payer

During the 30-month coordination period for patients with employer group health plan coverage, Medicare is secondary. Billing Medicare as primary during this period creates overpayments.

Cost Reports

Freestanding ESRD facilities file cost reports that CMS uses for wage index and other calculations. Errors can affect future payments and may be identified in desk reviews.

Preventing Improper Payments

Assessments and Plans of Care

• Track due dates for initial assessments, reassessments, and plan of care updates for every patient.

• Use templates that capture all required elements.

• Require interdisciplinary signatures and dates.

• Audit completion monthly.

Treatment Documentation

• Require complete treatment flow sheets for every session.

• Document reasons for shortened or missed treatments.

• Do not bill treatments that were not furnished.

• Document medical justification for additional treatments.

Height and Weight

• Follow CMS rules for measuring and reporting height and weight.

• Train staff on timing, especially for home patients.

• Audit claims data against records.

Physician Documentation

• Ensure monthly progress notes are documented for every patient.

• Coordinate with nephrology practices so notes are available in the facility record.

Drugs and Labs

• Document administration of every drug billed.

• For home patients, document dispensing and patient use.

• Reconcile drug inventory with claims.

• Ensure ESRD-related labs are billed by the facility under consolidated billing.

Claims Review

• Review claims before submission for treatments, drugs, comorbidities, height, weight, and modifiers.

• Use claim edits to catch common errors.

Compliance Program

• Follow OIG's General Compliance Program Guidance.

• Conduct regular internal audits using OIG's error categories.

• Train staff on documentation and billing.

• Report and return overpayments within 60 days under 42 CFR 401.305.

Responding to an Audit

• Calendar deadlines and gather complete records for each sampled claim, including assessments, plans of care, treatment flow sheets, physician notes, drug records, and lab results.

• Review records before submission and organize them by claim.

• Include a cover letter explaining how each claim meets requirements.

• Review OIG's preliminary findings carefully and respond with documentation.

• Challenge sampling methodology with a statistician when appropriate.

• Appeal MAC overpayment determinations under 42 CFR Part 405, Subpart I.

A Hypothetical Example

A dialysis organization conducts an internal audit modeled on OIG's provider compliance audits. It finds that several plans of care were updated late, that home patients' weights were recorded at inconsistent times, and that some monthly physician notes were missing from the facility record. The organization implements electronic tracking for assessment and plan due dates, standardizes weight measurement protocols, arranges for nephrology notes to be interfaced into the facility record, retrains staff, and reports and returns identified overpayments. A follow-up audit shows substantial improvement.

Understanding OIG's Audit Methodology

OIG's provider compliance audits follow a consistent approach. OIG identifies a population of claims for a defined period, selects a statistically valid random sample, requests medical records for each sampled claim, and has independent medical reviewers determine whether each claim met Medicare requirements. OIG then estimates the total amount of improper payments in the population and recommends that the provider refund the portion within the reopening period and exercise reasonable diligence to identify similar overpayments under the 60-day rule.

Because OIG estimates are extrapolated, a relatively small number of errors in a sample can produce a large estimated overpayment. Facilities should understand the methodology, request sampling information when they receive draft findings, and consider statistical review. OIG's DCI audit shows that providers can contest findings, since OIG revised determinations for 15 claims after reviewing DCI's comments.

Quality of Care and Payment

OIG emphasized in the DCI audit that many errors did not affect reimbursement directly but could affect quality of care. Missing assessments, incomplete plans of care, and missing physician progress notes may indicate gaps in care coordination. Facilities should treat these findings as quality issues as well as compliance issues. The ESRD Quality Incentive Program also links payment to quality measures, and survey agencies review compliance with the conditions for coverage, so documentation weaknesses can affect multiple areas.

The Role of the Medical Director

The medical director is responsible for quality assessment and performance improvement, staff education, and policies and procedures under the conditions for coverage. Medical directors should review compliance audit results, ensure that physician documentation standards are met, and lead corrective action. Medical director agreements should also be reviewed for compliance with the Anti-Kickback Statute and the physician self-referral law, since compensation must be consistent with fair market value and not tied to referrals.

Common Myths About Dialysis Audits

Myth: Bundled Payment Means Documentation Matters Less

Each billed treatment must be furnished and documented, and adjustments, outliers, and drug add-ons depend on documentation.

Myth: Only Large Chains Are Audited

OIG has audited large and small organizations, and MACs review claims from all facilities.

Myth: Conditions for Coverage Are Only a Survey Issue

OIG has treated missing assessments and plans of care as reasons claims did not meet Medicare requirements.

Myth: Home Dialysis Is Lower Risk

OIG's ongoing audit focuses specifically on home dialysis documentation, including dispensed medication.

Questions Leadership Should Ask

• Are assessments and plans of care completed on time for every patient?

• Do flow sheets document every billed treatment completely?

• Are height and weight measured and reported according to CMS rules?

• Are monthly physician notes in every patient record?

• Are drugs reconciled with administration records and claims?

• Are we ready for the results of OIG's home dialysis audit?

Key Takeaways

• The ESRD PPS base rate is $281.71 in 2026 and $297.52 in 2027.

• OIG found 70 of 100 sampled DCI claims noncompliant, estimating at least $14.2 million in unallowable payments.

• Common errors include assessment and plan of care gaps, incomplete treatments, measurement errors, and missing physician notes.

• OIG's home dialysis audit is in progress.

• Tracking, documentation standards, reconciliation, and internal audits reduce risk.

Responding to Draft OIG Findings

When OIG issues draft findings, the provider has an opportunity to submit written comments, which OIG considers and summarizes in the final report. Effective responses address each sampled claim individually with documentation, explain any records that were not located during the audit, identify errors in the reviewers' application of Medicare requirements, and raise any concerns about the sampling methodology with support from a statistician. Providers should also describe corrective actions already taken. A well-supported response can lead OIG to revise determinations, as it did in the DCI audit, and it creates a record for any later appeal of a MAC overpayment determination.

Building a Dialysis Compliance Program

OIG's General Compliance Program Guidance describes the elements of an effective compliance program, including written policies, a compliance officer and committee, training, effective communication, auditing and monitoring, enforcement of standards, and prompt response to detected problems. For dialysis organizations, risk areas include conditions for coverage documentation, treatment billing, drug billing, height and weight reporting, comorbidity coding, Medicare secondary payer, medical director and joint venture arrangements, and patient inducements such as assistance with insurance premiums, which have drawn government attention. A risk assessment that ranks these areas helps focus audits and training.

Preparing for Home Dialysis Scrutiny

With OIG's home dialysis audit expected to be completed in fiscal year 2026, facilities with home programs should prepare now. Key steps include confirming that training sessions are documented with dates, content, and competency, that home treatment logs are collected and reviewed, that drugs and supplies dispensed are documented with patient acknowledgment, that monthly assessments and physician notes are present, and that weights are measured and reported consistently. Facilities should also verify that home patients' plans of care address home-specific needs and that staff communications with patients are documented.

Monitoring Payment Rule Changes

CMS updates the ESRD PPS annually, typically with a proposed rule in the summer and a final rule in the fall. The CY 2027 final rule, for example, raised the base rate, added phosphate binders to the base rate, and updated the wage index and outlier policy. Facilities should review each final rule, update billing systems and protocols before January 1, and train staff on changes.

Facilities should also watch for MLN Matters articles and MAC instructions implementing each rule, since billing details often appear there.

Assign a staff member to monitor these updates throughout the year.

Timely updates prevent systematic billing errors.

Frequently Asked Questions

What is the 2026 ESRD PPS base rate?

$281.71 per treatment, increasing to $297.52 in 2027 under the CY 2027 final rule.

What did OIG find in its DCI audit?

That 70 of 100 sampled claims did not comply with Medicare requirements, with estimated unallowable payments of at least $14.2 million.

What are the most common OIG findings?

Incomplete assessments or plans of care, incomplete or undocumented treatments, height and weight errors, and missing physician progress notes.

Is OIG auditing home dialysis?

Yes. OIG's home dialysis audit is in progress with expected completion in fiscal year 2026.

What is ESRD consolidated billing?

The requirement that ESRD-related drugs, labs, and supplies be billed by the dialysis facility as part of the bundled payment.

Conclusion

OIG's dialysis audits show that compliance depends on fundamentals: timely assessments and plans of care, complete treatment documentation, accurate measurements, physician oversight, and proper drug and lab billing. Facilities that track these elements, audit regularly, and correct errors promptly will reduce improper payments and improve quality.

How HealthBridge Can Help

HealthBridge is a healthcare management consulting firm that helps dialysis facilities conduct OIG-style compliance audits, strengthen assessment and plan of care processes, improve treatment and drug documentation, review claims, and respond to audits. If your facility wants to reduce audit risk, please get in touch with us. We will be happy to help you with this topic.

References

• U.S. Department of Health and Human Services, Office of Inspector General. Medicare Dialysis Services Provider Compliance Audit: Dialysis Clinic, Inc. (A-05-20-00010). https://oig.hhs.gov/oas/reports/region5/52000010.asp

• U.S. Department of Health and Human Services, Office of Inspector General. Medicare Dialysis Services Provider Compliance Audit: Bio-Medical Applications of Arecibo, Inc. (A-02-17-01016). https://www.oversight.gov/sites/default/files/oig-reports/21701016.pdf

• U.S. Department of Health and Human Services, Office of Inspector General. Work Plan: Medicare Part B Audit of Home Dialysis Services (A-05-24-00006). https://www.oig.hhs.gov/reports-and-publications/workplan/summary/wp-summary-0000826.asp

• Centers for Medicare & Medicaid Services. Calendar Year 2026 ESRD Prospective Payment System Final Rule Fact Sheet. https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-end-stage-renal-disease-esrd-prospective-payment-system-final-rule

• Centers for Medicare & Medicaid Services. Calendar Year 2027 ESRD Prospective Payment System Final Rule Fact Sheet (CMS-1846-F). https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-end-stage-renal-disease-esrd-prospective-payment-system-final-rule-cms-1846-f

• Centers for Medicare & Medicaid Services. MLN Matters MM14313, ESRD and Acute Kidney Injury Dialysis: CY 2026 Update. https://www.cms.gov/files/document/mm14313-esrd-acute-kidney-injury-dialysis-cy-2026-update.pdf

• Electronic Code of Federal Regulations. 42 CFR Part 494, Conditions for Coverage for End-Stage Renal Disease Facilities. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-494

• Electronic Code of Federal Regulations. 42 CFR Part 413, Subpart H, Payment for End-Stage Renal Disease Services. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-413/subpart-H

• Centers for Medicare & Medicaid Services. Medicare Benefit Policy Manual, Chapter 11, End Stage Renal Disease. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/bp102c11.pdf

• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 8, Outpatient ESRD Hospital, Independent Facility, and Physician/Supplier Claims. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c08.pdf

• U.S. Department of Health and Human Services, Office of Inspector General. General Compliance Program Guidance. https://oig.hhs.gov/compliance/general-compliance-program-guidance/

• Electronic Code of Federal Regulations. 42 CFR 401.305, Requirements for Reporting and Returning of Overpayments. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-A/part-401/subpart-D/section-401.305

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.

The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.

HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.

© 2026 HealthBridge US, a California corporation. All rights reserved.

For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance

Legal

Resources